INTRODUCTION
============

Gastric cancer (GC) is the 5^th^ most common cancer and second leading cause of cancer-related deaths globally [@B21] ^,^ [@B32] ^,^ [@B36]. In 2016 there were an estimated 26,370 new cases of GC in the United States ^39^. The recent years have brought much progress regarding the genetics of GC and the number of confirmed GC associated SNPs and genes have risen dramatically [@B4] ^,^ [@B48]. In addition, several studies have supported the concept that environmental factors are critical components of GC pathogenesis [@B52]. However, genetic factors may modify the propensity for GC development through an alteration of the inflammatory state and may also interact with other risk factors [@B44].

Presently the mechanisms of the etiology and progression of GC are far from clear [@B4] ^,^ [@B38]. Several genes have been identified to be associated with GC risk, including Interleukin-10 (IL-10). IL-10 is a multifunctional cytokine with anti-inflammatory properties, which has been reported involving in the some malignancies progress and development [@B22] ^,^ [@B48]. The human gene that encodes IL-10 (Gene ID: 3586) maps to the long arm of chromosome 1 (1q31-32), which contains three most common 21082A\>G (rs1800896), 2592C\>A (rs1800872) and 2829C\>T (rs1800871) polymorphisms located within the promoter region. These polymorphisms are associated with low/high amount of IL-10 secretion [@B31] ^,^ [@B45].

A series of epidemiological studies have reported the association of -592A\>C (rs1800872) and -819T\>C (rs3021097) polymorphisms of IL-10 gene with GC risk [@B22] ^,^ [@B31] ^,^ [@B45], but the results remain conflicting rather than conclusive. Some meta-analyses previously published regarding the association of -592A\>C (rs1800872) and -819T\>C (rs3021097) polymorphisms with GC risk [@B4] ^,^ [@B48] ^,^ [@B55]. A few studies were not included in these meta-analyses and also original studies with larger sample sizes in different ethnicity have been published since then. In addition, some of the previous meta-analyses have reported conflicting conclusions.

Hence, we performed this meta-analysis to evaluate whether the IL-10 -592A\>C and -819T\>C polymorphisms contributed to the susceptibility of GC. Based on our knowledge, this is the most comprehensive and accurate meta-analysis of the association of IL-10 -592A\>C and -819T\>C polymorphisms with GC risk.

METHOD
======

Search strategy
---------------

The electronic databases of the US National Library of Medicine's PubMed, EMBASE, Web of Knowledge, Google Scholar, Wanfang, Chinese National Knowledge Infrastructure (CNKI), and Chinese Biomedical Literature Database (CBM) were systematically searched to retrieve potential publications that assessed the association between -592A\>C and -819T\>C polymorphisms of IL-10 gene and GC risk up to April 10, 2018. Key search terms used were as follows: (gastric cancer OR gastric neoplasm OR [stomach neoplasms](https://www.ncbi.nlm.nih.gov/mesh/68013274)) AND (Interleukin-10 OR IL-10) AND (-592A\>C OR rs1800872) AND (-819T\>C OR rs1800871) AND (Polymorphism OR SNP OR single nucleotide polymorphism OR variation OR mutation). This meta-analysis included only publications relating to humans, covering all relevant written in English and Chinese publications with available full-text articles. Reference lists of retrieved articles, review articles, and previous meta-analysis were also manually searched to avoid missing relevant studies.

Inclusion and exclusion criteria
--------------------------------

Studies were included in the meta-analysis if they met the following criteria: 1) full text available; 2) case-control or cohort studies; 3) studies focus on the association of -592A\>C (rs1800872) and -819T\>C (rs3021097) polymorphisms of IL-10 gene with GC risk; 4) sufficient published data for genotype and allele frequencies to calculate the Odds Ratio (OR) and 95% confidence interval (CI).

Major reasons for exclusion of studies were as follows: 1) abstract, review articles, case reports, unpublished data and comments; 2) studies with overlapped or duplicate data; 3) no healthy control group established in the study; 4) studies with unclear or ambiguous data or genotype frequencies. When duplicated studies were published by the same author obtained from the same patient sample, only the one with the largest sample size was included in this meta-analysis.

Data extraction
---------------

Data were carefully extracted from all eligible studies independently by two investigators according to the inclusion and exclusion criteria. The following data were collected from each study: first author, year of publication, country origin, ethnicity, total number of cases and controls, the frequencies of genotypes, minor allele frequencies (MAFs), p-value for Hardy-Weinberg equilibrium (HWE). In case of disagreement (in the data extraction), consensus was resolved through consensus, or a third author would assess these articles. In the current meta-analysis, the quality of selected studies was tested by the confirmation of HWE in control groups, and studies without the confirmation of HWE in controls were defined as low-quality studies, while studies with the confirmation of HWE in controls were defined as high-quality studies ([Table 1](#t1){ref-type="table"}).

TABLE 1The general characteristics of eligible studies in the meta-analysis of IL-10 -592A\>CFirst AuthorCountry (Ethnicity)CaseControlCasesControlsMAFsHWEGenotypesAlleleGenotypesAlleleAACACCACAACACCACWu 2003 [@B46]China (Asian)220230881052728115912783203371230.2670.231El-Omar 2003 [@B10]USA(Caucasian)314210351011781714571370127963240.771=0.001Savage 2004 [@B37]China (Asian)843869393657111491661712055670.7340.382Zambon 2005 [@B53]Italy (Caucasian)12964417427076182462453533379510.7380.696Alpizar-Alpizar 2005 [@B1]Costa Rica(Latinos)45453202127635211832580.6470.761Lee 2005 [@B25]Korea (Asian)122120526281667853607166740.3080.059Kamangar 2006 [@B19]Finland (Caucasian)112237638685017417821091323420.7210.775Sicinschi 2006 [@B39]Mexico (Latinos)18136940905117019295176983663720.5040.376Sugimoto 2007 [@B43]Japan (Asian)1051684354814070887010246900.2670.419Garcia 2008 [@B11]Spain (Caucasian)40440424143237191617281312451876210.7680.075Crusius 2008 [@B5]Netherland (Caucasian)237112211781481003748339764256316810.7490.049Deng 2008 [@B8]China (Asian)125110303956991513925461031170.531=0.001Xiao 2009 [@B47]China (Asian)220624100100203001402722836910382100.3370.718Kang 2009 [@B20]Korea (Asian)33333214215734441225146145414372270.3410.591Con 2009 [@B3]Costa Rica(Latinos)52191102616446023651031112710.7090.015Oh 2010 [@B33]China (Asian)178362778120235121167159364932310.3190.861Liu 2011 [@B27]China (Asian)234243999639294174109106283241620.3330.772He 2012 [@B14]China (Asian)19624882961826013292128283121840.3710.095Zeng 2012 [@B54]China (Asian)15115359771519510780667226800.2610.147Kim 2012 [@B22]Korea (Asian)49549523121450676314248191566873030.3060.041Pan 2013 [@B34]China (Asian)30830814412836416200142135314191970.3190.895Kuo 2014 [@B24]China (Asian)358358186134385062103581801415012150.340=0.001Hormazabal 2014 [@B31]Chile (Latinos)1471721973551111831183781052390.6940.070Yin 2015 [@B50]China (Asian)2284611129620320136235184426542680.2900.490de Oliveira 2015 [@B6]Brazil (Latinos)2072401048221290124169647402780.1620.753Ma 2016 [@B28]China (Asian)14715067631719797716712208920.3030.486

Statistical analysis
--------------------

All meta-analyses were conducted using Comprehensive Meta-Analysis (CMA) software (USA, version 2.2.064) and a p value below 0.05 was considered statistically significant. The strength of the association of -592A\>C and -819T\>C polymorphisms of IL-10 gene with GC risk was estimated by crude odds ratios (ORs) with corresponding 95% confidence intervals (CIs). The significance of the pooled OR was determined by the Z-test. An allele contrast model (C vs. T), homozygote model (CC vs. TT), heterozygote model (CT vs. TT), dominant (CC+CT vs. TT), and recessive (CC vs. CT+TT) model were used for IL-10 -819T\>C polymorphism. An allele contrast model (C vs. A), homozygote model (CC vs. AA), heterozygote model (CA vs. AA), dominant (CC+CA vs. AA), and recessive (CC vs. CA+AA) model were used for -592A\>C polymorphism. The Cochran chi-square-based Q statistical test was used to evaluate statistical between-study heterogeneity (with p\<0.05 for statistical significance). In addition, a quantitative measure of between-study heterogeneity was also investigated using the I[@B2] statistic, and which the between-study heterogeneity was considered low, moderate, and high based on I[@B2] values of 25%, 50%, and 75%, respectively[@B18]. If the between-study heterogeneity was statistically significant the random effects model[@B7] was applied; otherwise, the fixed effects model [@B29] was used. The sensitivity analysis was performed to assess the contribution of individual studies to pooled effect estimate by sequentially removing each study one at a time and computing differential estimates for rest. In addition, sensitivity analysis was performed by excluding the low quality studies to test the stability of the results. Publication bias was examined using the Begg's funnel plot and Egger's test [@B2] ^,^ [@B9]. If publication bias existed, the Duval and Tweedie non-parametric ''trim and fill'' method was used to adjust for it. Subgroup analyses by ethnicity and studies quality (by HWE status) were performed subsequently. The distribution of genotypes in control groups was evaluated for a departure from HWE using chi-square test.

RESULTS
=======

Characteristics of studies
--------------------------

[Tables 1](#t1){ref-type="table"} and 2 showed the characteristics of all the eligible studies selected in the meta-analysis. The study selection processes were presented in [Figure 1](#f1){ref-type="fig"} (PRISMA 2009 Flow Diagram). We evaluated all the retrieved studies by examining titles, abstracts and conclusions. According to the criteria eligibility, 44 studies in 29 publications was identified regarding the association between the IL-10 -592A\>C and -819T\>C polymorphisms with susceptibility to the GC. All of these 44 case-control studies provided sufficient data to calculate the association between the IL-10 -592A\>C [@B1] ^,^ [@B3] ^,^ [@B5] ^,^ [@B6] ^,^ [@B8] ^,^ [@B10] ^,^ [@B11] ^,^ [@B14] ^,^ [@B19] ^,^ [@B20] ^,^ [@B22] ^,^ [@B24] ^,^ [@B25] ^,^ [@B27] ^,^ [@B28] ^,^ [@B31] ^,^ [@B33] ^,^ [@B34] ^,^ [@B43] ^,^ [@B46] ^,^ [@B47] ^,^ [@B37] ^,^ [@B39] ^,^ [@B50] ^,^ [@B53] ^,^ [@B54] and -819T\>C [@B1] ^,^ [@B5] ^,^ [@B14] ^,^ [@B19] ^,^ [@B22] ^-^ [@B24] ^,^ [@B26] ^,^ [@B27] ^,^ [@B33] ^,^ [@B37] ^,^ [@B43] ^,^ [@B42] ^,^ [@B46] ^,^ [@B47] ^,^ [@B51] ^,^ [@B53] ^,^ [@B54] polymorphisms with risk of GC. The characteristics of the selected studies are summarized in [Tables 1](#t1){ref-type="table"} and 3. Among these studies, 26 case-control studies evaluated the association of the -592A\>C polymorphism with GC with 5,332 cases and 8,272 controls, included five groups of Caucasians [@B5] ^,^ [@B10] ^,^ [@B11] ^,^ [@B19] ^,^ [@B53], 16 groups of Asians [@B8] ^,^ [@B14] ^,^ [@B20] ^,^ [@B22] ^,^ [@B24] ^,^ [@B25] ^,^ [@B27] ^,^ [@B28] ^,^ [@B33] ^,^ [@B34] ^,^ [@B37] ^,^ [@B43] ^,^ [@B47] ^,^ [@B46] ^,^ [@B50] ^,^ [@B54], and five Latinos populations [@B1] ^,^ [@B3] ^,^ [@B6] ^,^ [@B31] ^,^ [@B39] ([Table 1](#t1){ref-type="table"}). While, 18 case-control studies evaluated the association between the -819T\>C polymorphisms and GC risk, with 3,431 cases and 6,109 controls, included three groups of Caucasians [@B5] ^,^ [@B19] ^,^ [@B53], 14 groups of Asians [@B14] ^,^ [@B22] ^-^ [@B24] ^,^ [@B26] ^,^ [@B27] ^,^ [@B33] ^,^ [@B37] ^,^ [@B42] ^,^ [@B43] ^,^ [@B46] ^,^ [@B47] ^,^ [@B51] ^,^ [@B54], and one Latinos populations[@B1] ([Table 2](#t2){ref-type="table"}). The countries of these studies included China, Korea, Japan, India, USA, Italy, Finland, Spain, Netherland, Costa Rica, Brazil, Mexico and Chile. All the genotype distributions of controls were in agreement with HWE for IL-10 -592A\>C and -819T\>C polymorphisms except for nine studies in five publications[@B11] ^,^ [@B21] ^,^ [@B30] ^,^ [@B31] ^,^ [@B40]. Therefore, 35 of 44 case-control studies were defined as high-quality studies ([Tables 1](#t1){ref-type="table"} and 2).

TABLE 2The general characteristics of eligible studies in the meta-analysis of IL-10 -819T\>CFirst AuthorCountry (Ethnicity)CaseControlCasesControlsMAFsHWEGenotypesAlleleGenotypesAlleleTTCTCCTCTTCTCCTCWu 2003 [@B46]China (Asian)220230881052728115912783203371230.2670.231Savage 2004 [@B37]China (Asian)843823738911256170163495032610.3410.314Zambon 2005 [@B53]Italy (Caucasian)12964417427076182462453533379510.7380.696Alpizar-Alpizar 2005 [@B1]Costa Rica (Latinos)45454162524663241830600.6660.179Kamangar 2006 [@B19]Finland (Caucasian)9815253558451511062801142220.7300.662Sugimoto 2007 [@B43]Japan (Asian)105168425761416986739245910.2700.194Crusius 2008 [@B5]European (Caucasian)22910941272145963628037863653816500.7540.023Xiao 2009 [@B47]China (Asian)22062410010020300140272283698274210.3370.718Oh 2010 [@B33]China (Asian)188379818720249127179158425162420.3190.425Su 2010 [@B42]China (Asian)4310018214572951436145550.2750.433Liu 2011 [@B27]China (Asian)234243999639294174109106283241620.3330.772He 2012 [@B14]China (Asian)19624882961826013292128283121840.3710.095Yuan 2012 [@B51]China (Asian)27929610812942345213142120344041880.3170.265Zeng 2012 [@B54]China (Asian)151153608011200102786510221850.2770.466Kim 2012 [@B22]Korea (Asian)49549523121450676314248191566873030.3060.041Kuo 2014 [@B24]China (Asian)35835819013236512204186132405042120.2960.028Kumar 2015 [@B23]India (Asian)2002503610361175225301191011793210.6420.574Li 2016 [@B26]China (Asian)15724836833815515936127851992970.5980.300

FIGURE 1Flow chart of studies selection in this meta-analysis (IL-10 -592A\>C and -819T\>C Polymorphisms)

Meta-analysis
-------------

### IL-10 -592A\>C Polymorphism

[Table 3](#t3){ref-type="table"} listed the main results of the meta-analysis of IL-10 -592A\>C polymorphism and GC risk. When all the eligible studies were pooled into the meta-analysis of IL-10 -592A\>C polymorphism, a significant association was found only under the heterozygote model (CA vs. AA: OR=1.153, 95% CI=1.020-1.305, p=0.023, [Figure 2](#f2){ref-type="fig"}A). In addition, significant between-study heterogeneity was detected in all genetic models. When stratified by ethnicity, a significant association between of IL-10 -592A\>C polymorphism and increased GC risk among Asians was detected under the allele model (C vs. A: OR=1.153, 95% CI=1.007-1.320, p=0.040) and the heterozygote model (CA vs. AA: OR=1.218, 95% CI=1.076-1.379, p= 0.002), but not among Caucasian and Latinos populations. Subgroup analysis of studies with high quality showed that there was a significant association between IL-10 -1082 A\>G polymorphism and increased risk of GC only under the allele model (OR=1.154, 95% CI=1.004-1.326, p=0.044, [Table 2](#t2){ref-type="table"}).

TABLE 3The meta-analysis of IL-10 -592A\>C polymorphism and risk of GCSubgroupStudy numberGenetic modelType of modelHeterogeneityOdds ratioPublication BiasI2 (%)PHOR95% CIZtestPORPBeggsPEggersOverall26C vs. ARandom76.40=0.0011.1040.982-1.2411.6570.0970.7240.97426CC vs. AARandom63.55=0.0011.0810.868-1.3450.6940.4880.4270.40126CA vs. AARandom44.340.0091.1531.020-1.3052.2680.0230.8600.56926CC+CA vs. AARandom89.63=0.0011.0850.828-1.4220.5890.5560.9640.55926CC vs. CA+ AARandom77.34=0.0011.0030.815-1.2350.0300.9760.1710.254By EthnicityCaucasian5C vs. ARandom67.190.0160.9920.797-1.235-0.0070.9440.8060.9535CC vs. AARandom65.330.0210.9590.572-1.608-0.1570.8750.8060.6015CA vs. AARandom60.260.0390.8910.540-1.470-0.4520.6511.0000.8695CC+CA vs. AARandom81.47=0.0011.1250.569-2.2230.3390.7350.4620.2525CC vs. CA+ AARandom55.560.0611.0710.922-1.2450.8950.3710.4620.456Asian17C vs. ARandom73.590.0011.1531.007-1.3202.0570.0400.2240.66417CC vs. AARandom59.740.0011.1930.937-1.5191.4290.1530.0290.00317CA vs. AARandom40.210.0441.2181.076-1.3793.1110.0020.5360.35617CC+CA vs. AARandom92.39=0.0011.1330.810-1.5850.7280.4670.4830.64817CC vs. CA+ AARandom81.80=0.0011.0500.755-1.4610.2900.7710.0520.013Latinos5C vs. ARandom87.97=0.0011.0530.660-1.6810.2160.8290.8060.7595CC vs. AARandom80.950.0010.5180.151-1.776-1.0470.2950.3080.3735CA vs. AAFixed20.760.2861.0010.707-1.4180.0070.9951.0000.7375CC+CA vs. AAFixed55.110.0830.9250.667-1.283-0.4690.6391.0000.5915CC vs. CA+ AARandom65.750.0330.7870.491-1.261-0.9970.3190.7340.757High Quality Studies    20C vs. ARandom77.22=0.0011.1541.004-1.3262.0120.0440.4170.79120CC vs. AARandom54.370.0021.1910.989-1.3421.8200.0690.3810.71720CA vs. AARandom45.140.0151.1310.982-1.3041.7100.0870.7210.87320CC+CA vs. AARandom63.33=0.0011.1760.997-1.3871.9300.0540.2560.63020CC vs. CA+ AAFixed31.810.0861.0790.961-1.2111.2850.1990.0400.029

FIGURE 2Forest plot of the association of IL-10 -592A\>C and -819T\>C Polymorphisms with GC: A) -592A\>C (homozygote model: C vs. A); B) -819T\>C (dominant model: CC+CT vs. TT)

### IL-10 -819T\>C Polymorphism

[Table 4](#t4){ref-type="table"} and [Figure 2](#f2){ref-type="fig"}B showed the main results of the meta-analysis of IL-10 -819T\>C polymorphism and GC risk. When all the eligible studies were pooled into the meta-analysis of IL-10 -819T\>C polymorphism, no significant association was observed in any genetic model. In the stratified analyses based on ethnicity and studies quality, there was not still significant association between IL-10 -819T\>C polymorphism and risk of GC.

TABLE 4The meta-analysis of IL-10 -819T\>C polymorphism and risk of GCSubgroupStudy numberGenetic modelType of modelHeterogeneityOdds ratioPublication BiasI2 (%)PHOR95% CIZtestPORPBeggsPEggersOverall18C vs. TRandom58.480.0011.0570.950-1.1771.0170.3090.8200.38118CC vs. TTRandom46.470.0160.9870.795-1.225-0.1200.9050.5440.46918CT vs. TTRandom44.860.0211.0920.943-1.2641.1710.2420.3240.37618CC+CT vs. TTRandom55.290.0021.0780.923-1.2590.9480.3430.4040.62118CC vs. CT+ TTFixed25.960.1501.0030.890-1.1310.0560.9550.4480.492By EthnicityCaucasian3C vs. TFixed50.640.1321.0860.914-1.2890.9370.3491.0000.9823CC vs. TTRandom66.660.0501.0080.474-2.1440.0210.9831.0000.7533CT vs. TTFixed59.860.0830.8030.524-1.232-1.0040.3151.0000.7993CC+CT vs. TTRandom67.420.0460.9380.445-1.980-0.1670.8671.0000.7443CC vs. CT+ TTFixed0.000.5521.1630.941-1.4381.3980.1621.0000.979Asian14C vs. TRandom63.820.0011.0460.924-1.1840.7080.4790.7420.49914CC vs. TTRandom49.480.0180.9870.778-1.254-0.1040.9170.6610.54514CT vs. TTRandom42.400.0471.1320.980-1.3071.6840.0920.7420.87914CC+CT vs. TTRandom57.220.0041.1050.942-1.2951.2240.2210.5840.82614CC vs. CT+ TTFixed20.330.2320.9170.792-1.062-1.1570.2470.1250.170High Quality Studies15C vs. TRandom54.220.0061.0850.966-1.2191.3770.1690.5520.39115CC vs. TTRandom52.770.0090.9740.742-1.278-0.1910.8480.6200.48815CT vs. TTRandom52.860.0081.0770.894-1.2970.7790.4360.2760.32615CC+CT vs. TTRandom61.510.0011.0630.874-1.2940.6110.5410.1980.46015CC vs. CT+ TTFixed30.610.1250.9800.848-1.132-0.2750.7840.3220.150

Heterogeneity and sensitivity analysis
--------------------------------------

As shown in [Tables 3](#t3){ref-type="table"} and 4, there was a significant between-study heterogeneity for IL-10 -592A\>C polymorphism under all genetic models (C vs. A: Ph=0.001; CC vs. AA: Ph=0.001; CA vs. AA: Ph=0.009; CC+CA vs. AA: Ph=0.001; CC vs. CA+ AA: Ph=0.001), and for of IL-10 -819T\>C (rs3021097) polymorphism under four genetic models (C vs. A: Ph=0.001; CC vs. TT: Ph=0.0160.001; CT vs. TT: Ph=021; and CC+CT vs. TT: Ph=0.002), except the recessive genetic model (CC vs. CT+ TT: Ph=0.150). We performed sensitivity analysis by omitting one study at a time and calculating the pooled ORs again. However, the results did not show any significant statistical differences when studies were omitted. Therefore, the stability of the study was not influenced by any individual study.

Publication bias
----------------

Both Begg's funnel plot and Egger's test were carried out to evaluate the publication bias of the studies. [Tables 3](#t3){ref-type="table"} and 4 presents the results of Begg's funnel plot and Egger's test under the five genetic models. As shown in [Figure 3](#f3){ref-type="fig"}A, the shapes of the Begg's funnel plots under the allele model of IL-10 -592A\>C polymorphism shown approximately symmetrical and significant evidence of publication bias was not observed by the Egger's test. As for the IL-10 -819T\>C polymorphism, the shapes of the Begg's funnel plots under the heterozygote comparison model seemed symmetrical ([Figure 3](#f3){ref-type="fig"}B). In addition, the Egger's tests (all p values for Egger's test\>0.05) also showed that there was no evidence of publication bias for both polymorphisms.

FIGURE 3Funnel plot for publication bias in the meta-analysis of the IL-10 -592A\>C and -819T\>C Polymorphisms with GC: A) -592A\>C (heterozygote model: CA vs. AA); B) -819T\>C (allele model: C vs. T).

DISCUSSION
==========

A meta-analysis can combine results from individual studies to overcome the limitation of small sample sizes and inadequate statistical power, produce a single estimate of the major effect, answer questions not resolved by the individual studies, resolve controversial debates arising from conflicting studies and cite limitations of current knowledge [@B12] ^,^ [@B15]. To date, several meta-analyses have been performed to evaluate the association of the IL-10 gene promoter -592A\>C and -819T\>C polymorphisms with GC. However, due to lack of ability to obtain overall reliable conclusions because of limited sample sizes, a consensus has not been reached. Therefore, to better elucidate the association of the IL-10 -592A\>C and -819T\>C polymorphisms with GC, we performed an updated and more comprehensive meta-analysis by collecting 44 relevant case-control studies in 29 publications.

In 2014, Qi et al., in a meta-analysis of twelve studies, with 2,116 GC cases and 4,077 controls, reported that there was no significant association between the IL-10 -592C\>A polymorphism and GC risk in overall population [@B35]. Since then, a series of better designed case-control studies on the association between IL-10 -592C\>A polymorphism and GC were performed. Therefore, their results as a meta-analysis essentially remain an open field. In the current meta-analysis, 26 eligible case-control studies with 5,332 cases and 8,272 controls were identified and analyzed. Our results showed that there was a significant association between the IL-10 -592C\>A polymorphism and susceptibility to GC in total population. Moreover, compared with Qi et al meta-analysis the allele genetic model and subgroup analysis among Latinos were also carried out. In this meta-analysis we found that the IL-10 -592C\>A polymorphism was associated with GC risk in Asians under the allele model (C vs. A: OR=1.153, 95% CI=1.007-1.320, p=0.040) and the heterozygote model (CA vs. AA: OR=1.218, 95% CI=1.076-1.379, p=0.002). In addition, it is worth noting that the association between IL-10 -592C\>A polymorphism and GC risk was significant by studies quality under the allele model (OR=1.154, 95% CI=1.004-1.326, p=0.044).

In 2016, Cui et al., performed a meta-analysis to assess the susceptibility of the IL-10 -819T\>C polymorphism to GC including eleven articles with 1,960 cases and 3,705 controls ^4^. Their results suggested that L-10 -819T\>C polymorphism has a protective role in susceptibility to GC. Although their results suggested that the IL-10 -819T\>C polymorphism might not contribute to the risk of GC; however, these studies were with small number of cases and controls. In the current meta-analysis, we included a total of 18 case-control studies with 3,431 cases and 6,109 controls. The pooled results indicated that there was no obvious association between IL-10 -819T\>C polymorphism to GC. Therefore, our meta-analysis not only confirmed Cui et al results, but also provided most reliable statistical results by including more seven case-control studies [@B4].

Heterogeneity between studies is common in the meta-analysis of genetic association studies [@B41] ^,^ [@B49]. In each case, the heterogeneity could be a result of different covariates such as ethnicity, sources of controls, sample size, HWE and methods used and so on [@B16] ^,^ [@B17] ^,^ [@B30]. In the current meta-analysis, significant between-study heterogeneity was detected across studies under all genetic models and thus we selected the random-effects model to summarize the ORs. Therefore, we performed meta-regression analysis to find the source of between-study heterogeneity. The results showed that ethnicity and studies quality did not contribute to substantial between-study heterogeneity in the current meta-analysis. Moreover, we have performed sensitivity analysis according to sample size and leave-one-out analysis to determine whether modification of the inclusion criteria by removing one study each time affected the results. However, for both IL-10 -592A\>C and -819T\>C polymorphisms, the sensitivity analyses did not materially affected the original results.

The present meta-analysis has some advantages compared to the previous meta-analyses. However, it does have some limitations that should be taken into account. First, we have included only studies published in the English and Chinese language in this meta-analysis; therefore, publication bias may have occurred. Second, in this meta-analysis the great proportion of statistical power was contributed by the Asian ethnicity. There were not enough studies in Caucasians and Latinos, which limited the statistical power. Moreover, African was one of the three largest ethnics, but we have not found any study on Africans. Third, the current meta-analysis was performed to analyze these polymorphisms separately; however, a haplotype analysis may have been more powerful for finding significant associations with GC. Forth, the ORs extracted from each eligible study were based on unadjusted estimates, while a more precise analysis should be performed in all individual data available, which would allow for the adjustment by other co-variants including age, environmental exposures, smoking status, and other lifestyle factors. Finally, gene-gene and gene-environment interactions which may modulate the GC susceptibility were not addressed in this meta-analysis for the lack of sufficient data.

CONCLUSION
==========

The current meta-analysis results inconsistent with the previous meta-analyses showed that the IL-10 -592A\>C polymorphism contributed to the susceptibility of GC in overall population, particularly in Asian populations. However, the IL-10 -819T\>C polymorphism was not associated with an increased risk of GC. Further large well-designed studies are still needed to determine the effects of the IL-10 -592A\>C and -819T\>C polymorphisms on GC.
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